Michael Spedding
occupation: researcher
Articles 188
-
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials
-
Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile
-
Environmental pharmacology-Dosing the environment: IUPHAR review 36
-
The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology
-
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY
-
Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet
-
Plan S: A threat to quality of science?
-
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets
-
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
-
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
-
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis
-
Altering the course of schizophrenia: progress and perspectives
-
The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression
-
Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats
-
The expanding role of immunopharmacology: IUPHAR Review 16
-
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands
-
Key challenges for the creation and maintenance of specialist protein resources
-
The Concise Guide to PHARMACOLOGY 2015/16: Overview
-
Creating a specialist protein resource network: a meeting report for the protein bioinformatics and community resources retreat
-
Acute tianeptine treatment selectively modulates neuronal activation in the central nucleus of the amygdala and attenuates fear extinction.
-
The hippocampal to prefrontal cortex circuit in mice: a promising electrophysiological signature in models for psychiatric disorders.
-
A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential.
-
Mitochondrial pharmacology: energy, injury and beyond.
-
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
-
International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands.
-
Changes in mitochondrial function are pivotal in neurodegenerative and psychiatric disorders: how important is BDNF?
-
Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat.
-
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands
-
The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?
-
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
-
The Concise Guide to PHARMACOLOGY 2013/14: overview
-
The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.
Human - wd:Q42388779